CIK: 0001617201 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $249,082 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLPG | GALAPAGOS ADR REP | 827,294 | $33,630 | 13.5% | $45.08 | — | SPON ADR | 36315X101 |
| MGTX | MEIRAGTX HOLDINGS | 4,050,714 | $28,436 | 11.4% | $7.75 | -36.3% | COM | G59665102 |
| STTK | SHATTUCK LABS | 2,782,797 | $19,841 | 8.0% | $4.75 | -42.6% | COM | 82024L103 |
| MDT | MEDTRONIC | 220,000 | $18,124 | 7.3% | $76.21 | -6.2% | SHS | G5960L103 |
| ORIC | ORIC PHARMACEUTICALS | 1,578,263 | $14,520 | 5.8% | $4.85 | +49.2% | COM | 68622P109 |
| KURA | KURA ONCOLOGY | 950,000 | $13,661 | 5.5% | $11.32 | -13.1% | COM | 50127T109 |
| BCRX | BIOCRYST PHARMACEUTICALS | 2,232,242 | $13,371 | 5.4% | $8.75 | -33.8% | COM | 09058V103 |
| ADCT | ADC THERAPEUTICS | 6,471,800 | $10,743 | 4.3% | $2.87 | -67.9% | SHS | H0036K147 |
| ABCL | ABCELLERA BIOLOGICS | 1,700,000 | $9,707 | 3.9% | $7.78 | -40.5% | COM | 00288U106 |
| QDEL | QUIDELORTHO | 118,920 | $8,764 | 3.5% | $85.35 | -20.8% | COM | 219798105 |
| PCRX | PACIRA BIOSCIENCES | 258,424 | $8,719 | 3.5% | $39.77 | -26.4% | COM | 695127100 |
| MIRM | MIRUM PHARMACEUTICALS | 293,301 | $8,658 | 3.5% | $23.37 | +29.5% | COM | 604749101 |
| PRTA | PROTHENA | 229,539 | $8,341 | 3.3% | $36.66 | +5.0% | SHS | G72800108 |
| OPCH | OPTION CARE HEALTH | 148,800 | $5,013 | 2.0% | $30.74 | -0.0% | COM NEW | 68404L201 |
| — | GALAPAGOS ADR REP | 120,000 | $4,878 | 2.0% | $40.65 | — | CALL | 36315X901 |
| NBIX | NEUROCRINE BIOSCIENCES | 35,900 | $4,730 | 1.9% | $100.70 | +14.3% | COM | 64125C109 |
| UHS | UNIVERSAL HEALTH SERVICES CL B | 28,090 | $4,282 | 1.7% | $135.05 | -1.3% | CL B | 913903100 |
| — | GRAPHITE BIO | 1,351,939 | $3,542 | 1.4% | $2.94 | — | COM | 38870X104 |
| — | KEZAR LIFE SCIENCES | 3,365,333 | $3,188 | 1.3% | $4.51 | — | COM | 49372L100 |
| NUVB | NUVATION BIO CL A | 2,050,000 | $3,096 | 1.2% | $1.50 | -14.1% | COM CL A | 67080N101 |
| KIDS | ORTHOPEDIATRICS | 95,000 | $3,088 | 1.2% | $29.00 | 0.0% | COM | 68752L100 |
| PRVA | PRIVIA HEALTH GROUP | 132,158 | $3,044 | 1.2% | $22.38 | 0.0% | COM | 74276R102 |
| DXCM | DEXCOM | 23,000 | $2,854 | 1.1% | $112.73 | -9.4% | COM | 252131107 |
| — | MURAL ONCOLOGY | 418,505 | $2,478 | 1.0% | $5.92 | — | ORD SHS | G63365103 |
| — | PROTHENA | 53,500 | $1,944 | 0.8% | $36.34 | — | CALL | G72800908 |
| MDRX | VERADIGM | 180,000 | $1,888 | 0.8% | $12.26 | 0.0% | COM | 01988P108 |
| — | ORIC PHARMACEUTICALS | 200,000 | $1,840 | 0.7% | $9.20 | — | CALL | 68622P909 |
| BBSI | BARRETT BUSINESS SERVICES | 13,000 | $1,505 | 0.6% | $22.58 | +12.1% | COM | 068463108 |
| ERAS | ERASCA | 599,458 | $1,277 | 0.5% | $2.70 | -21.9% | COM | 29479A108 |
| SYRE | SPYRE THERAPEUTICS | 55,000 | $1,184 | 0.5% | $13.78 | 0.0% | COM NEW | 00773J202 |
| — | SHOCKWAVE MEDICAL | 5,000 | $953 | 0.4% | $190.56 | — | COM | 82489T104 |
| DSGN | DESIGN THERAPEUTICS | 280,000 | $742 | 0.3% | $4.66 | -50.9% | COM | 25056L103 |
| BMEA | BIOMEA FUSION | 42,991 | $624 | 0.3% | $18.03 | -32.6% | COM | 09077A106 |
| ALKS | ALKERMES | 15,000 | $416 | 0.2% | $26.01 | -0.1% | SHS | G01767105 |